Cost of Drugs for Extensively Resistant Tuberculosis in 8 European Countries, 2017–2024

37 observations of drug cost data for extensively drug-resistant tuberculosis (XDR-TB) across 8 European countries, spanning 2017 to 2024. The dataset is sourced from Our World in Data and repackaged by Electric Sheep Europe.

Use Cases

• Analyze the cost trends of XDR-TB drugs over time based on the 2017–2024 date range.
• Compare drug cost variations across different European countries based on the geographic coverage.
• Estimate the economic burden of treating drug-resistant tuberculosis based on the cost data.

Strengths

• 37 observations provide a specific data point count.
• Covers 8 European countries, indicating a multi-national scope.
• Spans 7 years (2017–2024), offering a multi-year temporal perspective.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Our World in Data

Time Range

2017–2024

Freshness

Last updated 2026-06-03 18:32:09; freshness should be verified.

Geography

8 European countries